Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

JAZZ

Jazz Pharmaceuticals plc

Nov 29 • 10:10AM ET

115.39

Dollar change +0.90
Percentage change 0.79	%

Healthcare • Biotechnology • Ireland • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	191.46	EPS (ttm)	0.60	Insider Own	3.12%	Shs Outstand	63.21M	Perf Week	-2.44%
Market Cap	7.26B	Forward P/E	5.81	EPS next Y	19.85	Insider Trans	-0.85%	Shs Float	60.99M	Perf Month	-7.66%
Income	79.95M	PEG	17.09	EPS next Q	5.13	Inst Own	90.58%	Short Float / Ratio	4.21% / 3.87	Perf Quarter	-20.59%
Sales	3.79B	P/S	1.91	EPS this Y	39.75%	Inst Trans	-0.76%	Short Interest	2.57M	Perf Half Y	-9.96%
Book/sh	55.44	P/B	2.08	EPS next Y	7.62%	ROA	0.74%	Target Price	194.44	Perf Year	-25.05%
Cash/sh	25.19	P/C	4.58	EPS next 5Y	11.20%	ROE	2.56%	52W Range	111.25 - 160.96	Perf YTD	-27.57%
Dividend	-	P/FCF	5.84	EPS past 5Y	-	ROI	0.92%	52W High	-28.31%	Beta	0.66
Dividend %	-	Quick Ratio	1.67	Sales past 5Y	17.93%	Gross Margin	71.28%	52W Low	3.72%	ATR	3.76
Employees	2800	Current Ratio	2.06	Sales Q/Q	3.35%	Oper. Margin	14.99%	RSI (14)	36.56	Volatility	3.04% 3.26%
Optionable	Yes	Debt/Eq	1.66	EPS Q/Q	758.17%	Profit Margin	2.11%	Rel Volume	0.69	Prev Close	114.49
Shortable	Yes	LT Debt/Eq	1.48	Earnings	Nov 08 AMC	Payout	-	Avg Volume	663.62K	Price	115.39
Recom	1.56	SMA20	-6.76%	SMA50	-9.63%	SMA200	-13.75%	Volume	67,102	Change	0.79%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-27-23	Downgrade	UBS	Buy → Neutral	$170 → $135
Sep-29-23	Initiated	Raymond James	Mkt Perform
Jun-12-23	Resumed	Wells Fargo	Equal Weight	$184 → $140
Dec-09-22	Upgrade	Goldman	Neutral → Buy	$192 → $190
Jun-14-22	Initiated	UBS	Buy	$194
Apr-06-22	Downgrade	Goldman	Buy → Neutral	$202 → $196
Nov-19-21	Resumed	Goldman	Buy	$198
Oct-07-21	Resumed	Jefferies	Buy	$172
Oct-05-21	Initiated	Citigroup	Buy	$200
Sep-23-21	Initiated	Needham	Buy	$220
May-19-21	Resumed	JP Morgan	Overweight	$183 → $206
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$186
Feb-05-21	Reiterated	H.C. Wainwright	Buy	$195 → $207
Feb-03-21	Upgrade	Piper Sandler	Neutral → Overweight	$150 → $175
Jan-29-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-16-20	Initiated	UBS	Buy	$174
Nov-03-20	Reiterated	H.C. Wainwright	Buy	$185 → $195
Oct-09-20	Reiterated	H.C. Wainwright	Buy	$175 → $185
Sep-14-20	Resumed	JP Morgan	Overweight	$175
Sep-14-20	Downgrade	Goldman	Neutral → Sell	$128

Show Previous Ratings

Nov-27-23 09:49AM	5 Best Upside Stocks To Buy Now (Insider Monkey)
Nov-15-23 05:21AM	3 No-Brainer Stocks to Buy With $200 Right Now (Motley Fool)
Nov-14-23 12:50PM	12 Best Value Stocks To Buy Heading Into 2024 (Picked By Seth Klarman) (Insider Monkey)
02:00AM	Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders (Business Wire)
Nov-09-23 05:07PM	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2023 Earnings Call Transcript (Insider Monkey) -9.14%
07:00PM	Loading…
Nov-08-23 07:00PM	Compared to Estimates, Jazz (JAZZ) Q3 Earnings: A Look at Key Metrics (Zacks)
05:52PM	Jazz Pharmaceuticals PLC (JAZZ) Reports Solid Q3 2023 Results and Raises Revenue Guidance (GuruFocus.com)
04:42PM	Jazz: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance (PR Newswire)
Nov-07-23 12:33PM	Unlocking Q3 Potential of Jazz (JAZZ): Exploring Wall Street Estimates for Key Metrics (Zacks)
07:45AM	Jazz Pharmaceuticals and MD Anderson Announce Five-Year Collaboration to Evaluate Zanidatamab in HER2-Expressing Cancers (PR Newswire)
Nov-01-23 04:15PM	Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences (PR Newswire)
10:01AM	Jazz Pharmaceuticals (JAZZ) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-31-23 05:42PM	10 Stocks That Will Skyrocket (Insider Monkey)
Oct-30-23 04:05PM	11 Best Long-Term Stocks To Buy For High Returns (Insider Monkey)
11:40AM	Loading…
Oct-26-23 11:40AM	JAZZ vs. ZTS: Which Stock Is the Better Value Option? (Zacks)
Oct-25-23 04:15PM	Jazz Pharmaceuticals to Report 2023 Third Quarter Financial Results on November 8, 2023 (PR Newswire)
08:34AM	Strength Seen in ImmunoGen (IMGN): Can Its 11.7% Jump Turn into More Strength? (Zacks)
08:30AM	Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030 (PR Newswire)
Oct-23-23 07:45AM	Jazz Pharmaceuticals Presents Data Highlighting the Continued Need for Low-Sodium Treatment Option Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Real-World, Evidence-Based Approaches for Individualized Treatment in Adults with Narcolepsy at World Sleep 2023 (PR Newswire)
Oct-21-23 06:38AM	Wyndham rebuffs Choice Hotels; Southwestern surges on M&A talk: 4 big deal reports (Investing.com)
Oct-20-23 10:30AM	Jazz Pharmaceuticals Said to Explore Options Including Sale (Bloomberg)
Oct-18-23 07:55AM	5 Value Stocks With High Earnings Yield to Boost Your Portfolio (Zacks)
07:45AM	Jazz Pharmaceuticals to Present Latest Advancements in Sleep Medicine at World Sleep 2023 (PR Newswire)
Oct-17-23 09:55AM	Does Jazz (JAZZ) Have the Potential to Rally 47.29% as Wall Street Analysts Expect? (Zacks)
04:21AM	Jazz (JAZZ) Soars 5.3%: Is Further Upside Left in the Stock? (Zacks)
Oct-16-23 07:45AM	Jazz Pharmaceuticals to Showcase Growing Impact in Solid Tumor Oncology Research at ESMO 2023 (PR Newswire) +5.33%
Oct-13-23 08:15AM	What Makes Jazz Pharmaceuticals plc (JAZZ) a Prospective Investment Bet? (Insider Monkey)
Oct-10-23 11:40AM	JAZZ or ZTS: Which Is the Better Value Stock Right Now? (Zacks)
Oct-06-23 10:15AM	Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report Puts Patients at the Center (ACCESSWIRE)
02:58PM	Loading…
Oct-04-23 02:58PM	15 Stocks Billionaire Seth Klarman Likes the Most Now (Insider Monkey)
Oct-02-23 05:21AM	5 Genius Safe Stocks to Buy for the 4th Quarter of 2023 (Motley Fool)
Sep-30-23 05:06AM	4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip (Motley Fool)
Sep-27-23 02:38PM	3 Cannabis Stocks That Should Be on Every Investors Radar This Fall (InvestorPlace)
Sep-22-23 11:57AM	Jazz Pharma (JAZZ) Gets EU Nod for Cancer Drug Enrylaze (Zacks)
Sep-21-23 05:41PM	Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze® (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (PR Newswire)
Sep-20-23 02:15PM	3 Biotech Stocks That Should Be on Every Investors Radar This Fall (InvestorPlace)
Sep-19-23 06:45AM	7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom (InvestorPlace)
Sep-13-23 04:15PM	Jazz Pharmaceuticals to Participate in Three Upcoming Investor Conferences (PR Newswire)
Sep-12-23 07:30AM	Jazz Pharmaceuticals Announces Key Update to Leadership Team (PR Newswire)
Sep-11-23 07:45AM	Jazz Pharmaceuticals Showcases Impact of Sleep Medicine Portfolio at Psych Congress 2023 (PR Newswire)
Sep-08-23 11:30AM	Why Is Jazz (JAZZ) Up 0.4% Since Last Earnings Report? (Zacks)
Aug-26-23 07:25AM	Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030 (Motley Fool)
Aug-24-23 04:15PM	Jazz Pharmaceuticals to Participate in Citi's 18th Annual BioPharma Conference (PR Newswire)
Aug-15-23 09:01PM	Insider Sell: Patricia Carr Sells 158 Shares of Jazz Pharmaceuticals PLC (GuruFocus.com)
Aug-11-23 07:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
11:07AM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
09:08AM	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-09-23 09:00PM	Jazz (JAZZ) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:30PM	Jazz Pharmaceuticals (JAZZ) Q2 Earnings and Revenues Top Estimates (Zacks)
04:20PM	Jazz: Q2 Earnings Snapshot (AP Finance)
04:05PM	Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance (PR Newswire)
Aug-08-23 11:37PM	3 Biotech Stocks Youll Regret Not Buying Soon (InvestorPlace)
03:56PM	20 Cities with the Cheapest Weed in the World (Insider Monkey)
11:20AM	Is a Surprise Coming for Jazz Pharmaceuticals (JAZZ) This Earnings Season? (Zacks)
06:20AM	15 Worst Performing Biotech Stocks in 2023 (Insider Monkey)
Aug-02-23 02:10PM	Jazz Pharmaceuticals enters into Letter of Intent with the pan-Canadian Pharmaceutical Alliance (pCPA) for Rylaze®, helping address the unmet need of acute lymphoblastic leukemia and lymphoblastic lymphoma patients across Canada (PR Newswire)
Jul-28-23 10:56AM	The Zacks Analyst Blog Highlights Jazz Pharmaceuticals, Oshkosh and StoneCo (Zacks)
Jul-27-23 10:25AM	3 Stocks to Buy as Recession Looks Unlikely (Zacks)
Jul-26-23 04:15PM	Jazz Pharmaceuticals to Report 2023 Second Quarter Financial Results on August 9, 2023 (PR Newswire)
10:02AM	Jazz Pharmaceuticals (JAZZ) to Report Q2 Results: Wall Street Expects Earnings Growth (Zacks)
Jul-21-23 08:08AM	Jazz Pharmaceuticals Receives CHMP Positive Opinion for JZP458 (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (PR Newswire)
Jul-19-23 09:55AM	Wall Street Analysts Think Jazz (JAZZ) Could Surge 54.74%: Read This Before Placing a Bet (Zacks)
08:21AM	12 Cheap Value Stocks To Buy According To Seth Klarman (Insider Monkey)
Jul-11-23 11:40AM	JAZZ vs. ZTS: Which Stock Is the Better Value Option? (Zacks)
Jul-08-23 05:06AM	4 Unequaled Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip (Motley Fool)
Jul-07-23 12:00PM	Pro Picks: 4 founder-led diamonds (Investing.com)
Jun-23-23 09:57AM	Jazz Pharmaceuticals Sues FDA Over Approval Of Rival Product, Calls It 'Unlawful' (Benzinga)
Jun-21-23 08:00PM	JAZZ: Raising target price to $141.00 (Argus Research)
Jun-09-23 11:30AM	Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report? (Zacks)
10:55AM	13 Best Future Stocks for the Long-Term (Insider Monkey)
Jun-02-23 06:41PM	Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers (PR Newswire)
03:55PM	10 Stocks Jim Cramer and Hedge Funds Have In Common (Insider Monkey)
May-31-23 07:45AM	Jazz Pharmaceuticals Demonstrates Continued Leadership in Sleep Medicine with New Data Presentations at SLEEP 2023 (PR Newswire)
May-30-23 04:15PM	Jazz Pharmaceuticals to Participate in the 2023 Goldman Sachs Global Healthcare Conference (PR Newswire)
May-25-23 04:15PM	Jazz Pharmaceuticals to Host Zanidatamab KOL Investor Webcast on June 2, 2023 (PR Newswire)
May-10-23 07:00PM	Compared to Estimates, Jazz (JAZZ) Q1 Earnings: A Look at Key Metrics (Zacks)
05:45PM	Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates (Zacks)
04:37PM	Jazz: Q1 Earnings Snapshot (AP Finance)
04:05PM	Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance (PR Newswire)
11:00AM	Take a Look Under the Microscope at These Two Biopharma Stocks (TheStreet.com)
May-08-23 10:00AM	Analysts Estimate Gain Therapeutics, Inc. (GANX) to Report a Decline in Earnings: What to Look Out for (Zacks)
May-05-23 03:44PM	Why Shares of Avadel Soared This Week (Motley Fool)
May-02-23 04:15PM	Jazz Pharmaceuticals to Participate in the 2023 RBC Capital Markets Global Healthcare Conference (PR Newswire)
Apr-27-23 07:30AM	Jazz Pharmaceuticals to Showcase Rapidly Expanding Oncology Pipeline and Advances in Current Product Portfolio at ASCO 2023 (PR Newswire)
Apr-26-23 08:00PM	JAZZ: Rating decreased to a HOLD (Argus Research)
04:15PM	Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on May 10, 2023 (PR Newswire)
10:01AM	Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Q1 Release (Zacks)
Apr-19-23 07:45AM	Jazz Pharmaceuticals to Present Advancements in Neuroscience at American Academy of Neurology Annual Meeting (PR Newswire)
Apr-14-23 11:30AM	Catalyst (CPRX) Up 14.1% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-31-23 11:30AM	Jazz (JAZZ) Up 0.4% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-30-23 07:44AM	Jazz Pharmaceuticals Expands Support of the American Heart Association to Raise Awareness of the Link Between Sleep Disorders and Heart Health (PR Newswire)
Mar-21-23 06:45AM	My Top Cannabis Stock to Buy in 2023 and Hold For 10 Years (Motley Fool)
Mar-15-23 07:00AM	Jazz Pharmaceuticals to Present Data at 2023 AACR Annual Meeting Showcasing New Zepzelca® (lurbinectedin) Data and Expanded Oncology Pre-Clinical and Clinical Pipeline (PR Newswire)
Mar-08-23 08:00AM	Jazz Pharmaceuticals Secures Eight Additional Provincial Reimbursements for Vyxeos® for Treatment of Adults with Newly Diagnosed Therapy-Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia-Related Changes (PR Newswire)
06:27AM	Those who invested in Jazz Pharmaceuticals (NASDAQ:JAZZ) three years ago are up 29% (Simply Wall St.)
Mar-06-23 01:07AM	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-03-23 01:31PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
Mar-01-23 05:35PM	Jazz Pharmaceuticals (JAZZ) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance (PR Newswire)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Patil Neena M	EVP & Chief Legal Officer	Sep 01	Sale	144.25	1,500	216,375	29,186	Sep 06 05:09 PM
Carr Patricia	SVP, Chief Accounting Officer	Aug 29	Sale	143.47	142	20,373	5,986	Aug 31 06:44 PM
Patil Neena M	EVP & Chief Legal Officer	Aug 15	Sale	139.59	750	104,695	30,686	Aug 17 05:21 PM
McSharry Heather Ann	Director	Aug 14	Sale	138.16	1,344	185,685	16,778	Aug 15 05:52 PM
O'Keefe Kenneth W	Director	Aug 14	Sale	138.16	1,241	171,455	24,723	Aug 15 07:49 PM
ENRIGHT PATRICK G	Director	Aug 14	Sale	138.16	1,241	171,455	20,946	Aug 15 05:45 PM
Sohn Catherine A.	Director	Aug 14	Sale	138.16	1,241	171,455	14,868	Aug 15 06:02 PM
Winningham Rick E	Director	Aug 14	Sale	138.16	1,241	171,455	10,444	Aug 15 06:08 PM
Gray Peter	Director	Aug 14	Sale	138.16	1,241	171,455	16,068	Aug 15 05:47 PM
Cook Jennifer E.	Director	Aug 14	Sale	138.16	1,241	171,454	7,305	Aug 15 05:44 PM
RIEDEL NORBERT G	Director	Aug 14	Sale	138.16	1,241	171,454	13,705	Aug 15 05:58 PM
ORiordan Anne	Director	Aug 14	Sale	138.16	1,241	171,454	12,551	Aug 15 07:51 PM
Smith Mark Douglas	Director	Aug 14	Sale	138.16	1,241	171,454	7,305	Aug 15 06:00 PM
Carr Patricia	SVP, Chief Accounting Officer	Aug 14	Sale	138.16	158	21,829	6,128	Aug 15 05:43 PM
Mulligan Seamus	Director	Jun 08	Option Exercise	81.76	4,500	367,920	1,169,300	Jun 12 04:47 PM
Carr Patricia	SVP, Chief Accounting Officer	Jun 07	Sale	127.92	126	16,117	6,286	Jun 09 04:55 PM
Patil Neena M	EVP & Chief Legal Officer	Jun 01	Sale	127.98	1,600	204,763	32,826	Jun 05 08:24 PM
GALA RENEE D	EVP & Chief Financial Officer	May 18	Sale	131.75	6,000	790,474	35,978	May 19 08:45 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 15	Sale	133.22	1,023	136,284	6,286	Mar 17 06:10 PM
Sablich Kim	EVP, GM of U.S., Commercial Ma	Mar 08	Sale	139.74	3,013	421,043	30,560	Mar 10 06:10 PM
O'Keefe Kenneth W	Director	Mar 07	Option Exercise	81.76	4,500	367,920	25,579	Mar 09 06:34 PM
O'Keefe Kenneth W	Director	Mar 07	Sale	138.39	2,690	372,267	22,889	Mar 09 06:34 PM
Larkin Finbar	SVP, Technical Operations	Mar 07	Sale	140.76	2,075	292,081	21,779	Mar 07 09:33 PM
Larkin Finbar	SVP, Technical Operations	Mar 06	Option Exercise	58.72	1,706	100,176	25,560	Mar 07 09:33 PM
Larkin Finbar	SVP, Technical Operations	Mar 06	Sale	143.92	1,706	245,526	23,854	Mar 07 09:33 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 05	Sale	140.76	1,148	161,594	7,309	Mar 07 09:18 PM
Mulligan Seamus	Director	Mar 04	Option Exercise	59.13	4,500	266,085	1,164,800	Mar 07 08:30 PM
Pearce Samantha	SVP, Head of Europe & Internat	Feb 02	Option Exercise	109.45	531	58,118	11,840	Feb 06 04:26 PM
Pearce Samantha	SVP, Head of Europe & Internat	Feb 02	Sale	157.26	531	83,505	11,309	Feb 06 04:26 PM
COZADD BRUCE C	Chairman & CEO	Feb 01	Sale	155.79	1,000	155,790	367,078	Feb 03 06:45 PM
Pearce Samantha	SVP, Head of Europe & Internat	Jan 03	Option Exercise	109.45	531	58,118	11,840	Jan 05 06:43 PM
COZADD BRUCE C	Chairman & CEO	Jan 03	Sale	159.86	3,000	479,590	368,078	Jan 05 06:41 PM
Pearce Samantha	SVP, Head of Europe & Internat	Jan 03	Sale	159.59	531	84,742	11,309	Jan 05 06:43 PM
GALA RENEE D	EVP & Chief Financial Officer	Dec 21	Sale	160.00	2,635	421,600	32,558	Dec 22 04:53 PM
Pearce Samantha	SVP, Head of Europe & Internat	Dec 13	Option Exercise	109.45	531	58,118	11,840	Dec 15 06:29 PM
Pearce Samantha	SVP, Head of Europe & Internat	Dec 13	Sale	155.45	531	82,544	11,309	Dec 15 06:29 PM
Iannone Robert	EVP, Global Head of R&D	Dec 09	Sale	151.54	1,844	279,440	36,316	Dec 13 05:16 PM
Carr Patricia	SVP, Chief Accounting Officer	Dec 05	Sale	152.06	63	9,580	5,934	Dec 07 06:38 PM
Smith Mark Douglas	Director	Dec 02	Sale	154.68	420	64,966	5,471	Dec 06 06:57 PM
Cook Jennifer E.	Director	Dec 02	Sale	154.68	420	64,966	5,471	Dec 06 07:01 PM
COZADD BRUCE C	Chairman & CEO	Dec 01	Sale	157.00	1,000	157,000	371,078	Dec 05 05:03 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JAZZ

Jazz Pharmaceuticals plc

Upgrade your FINVIZ experience